drugset / Trial / NCT07396714

the Efficacy of Ivermectin Alone or With Microneedling in Treatment of Cutaneous Warts.

NCT07396714

Phase 0 Not yet recruiting 88 enrolled Assiut University
RandomizedParallel-groupSingle-blindTreatment

Summary

To compare between the efficacy and safety of topical ivermectin alone, microneedling with topical ivermectin and topical salicylic acid in treatment of cutaneous warts. topical ivermectin 1% will be applied on warts whole night clinical assessment will be done every 2 weeks Microneedling will be performed on the lesion using a microneedling pen type device with a 1-cm tip diameter at a 2-mm depth setting for 2-3 minutes until pinpoint bleebing occurs 1 mL of topical ivermectin 1% will be applied on to the wart tissue. Sessions: Sessions will be performed every 2 weeks until complete cure or for maximum 6 sessions (total 3 month)

Timeline

Start
2026-02-01
Primary completion
2027-02-01
Completion
2027-06-01

Publications

  • Background Mehta N. Case study of oral ivermectin in patients with cutaneous warts. J Cardiovasc Dis Res. 2024;15(12):6438-46

Drugs

EvaluationDrugModalityDoseRoute
Subject Ivermectin Small molecule 1 % Topical
Comparator salicylic acid Small molecule Topical